Kenvue Inc. (KVUE) To Go Ex-Dividend on August 12th

Kenvue Inc. (NYSE:KVUE) declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Wednesday, August 12th will be paid a dividend of 0.21 per share on Wednesday, August 26th. This represents a c) annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a 1.2% increase from Kenvue’s previous quarterly dividend of $0.21.

Kenvue has a payout ratio of 68.9% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 68.3%.

Kenvue Stock Performance

NYSE:KVUE opened at $19.22 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The stock has a market capitalization of $36.92 billion, a P/E ratio of 22.09, a PEG ratio of 1.47 and a beta of 0.47. The company has a 50 day moving average price of $18.77 and a 200 day moving average price of $18.09. Kenvue has a fifty-two week low of $14.02 and a fifty-two week high of $21.95.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. During the same period in the previous year, the firm earned $0.29 EPS. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts forecast that Kenvue will post 1.15 EPS for the current year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.